Back to database
2.5/5 Weak evidence

Joint support evidence brief

Boswellia serrata

Clinical osteoarthritis evidence is more developed than sport evidence; this is not a general gym recovery or performance supplement.

Joint pain evidence, not ergogenic health / recovery 6 linked sources Content audit 2026-05-04

Headline Finding

OA meta-analysis supports possible pain/function benefit; sport soreness evidence is early and not performance-focused.

Dose Context

Boswellic-acid standardization and extract type are central. Ordinary frankincense, blends, and branded extracts cannot be scored as one product.

Important Caveat

Potential value is joint-symptom support, not strength, hypertrophy, or training adaptation. Medication interactions and GI tolerance still need screening.

Source Drawer

Linked Research

6 papers and evidence links - audit 2026-05-04
  1. Meta-analysis OA systematic review and meta-analysis
  2. Trial Exercise soreness RCT
  3. Trial Knee OA pilot RCT
  4. Trial Knee OA placebo RCT
  5. Safety LiverTox safety summary
  6. Safety NCCIH safety overview

How To Read This Rating

The score reflects evidence that the supplement does its stated job. Some jobs are direct, such as strength, endurance, or recovery; others are indirect, such as sleep, mood, appetite, or health support. A real effect can still receive a cautious practical rating when dose, safety, product quality, or audience fit remain uncertain.

Spot An Evidence Issue?

Send the disputed claim, source link, and why it changes the practical verdict. Corrections that materially affect the claim, dose, caveat, or rating are prioritized.

Report a source or rating issue